glp 1 pen tirzepatida Lilly launches lower-price weight-loss drug Zepbound without injector Diabetes Patients Also Struggle to

The Impact of Environmental Factors on the Secretion of Gastrointestinal Hormones

However, beyond the efficacy for metabolic control, the current guidelines of diabetes mellitus pharmacotherapy are directed towards protection in the cardiovascular health and other complications, for which this pharmacological group is positioned as an important option, demonstrating a reduction of cardiovascular events compared to placebo which may be comparable to recent result from SGLT-2 inhibitors

Zepbound and Mounjaro contain the same active ingredient (tirzepatide) and are both manufactured by Eli Lilly

Luo ZY, Li X, Chen CT, et al